Free release
1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea

1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea

CAS No. :475108-18-0MDL No. :MFCD15146788Formula :C22H19ClN4O5Boiling Point :-Linear Structure Formula :-InChI Key :SPMV

Sales:Service@apichina.com
CAS No. :475108-18-0 Brand :Qitai
Formula :C22H19ClN4O5 M.W :454.86

Introduction

CAS No. :475108-18-0 MDL No. :MFCD15146788
Formula : C22H19ClN4O5 Boiling Point : -
Linear Structure Formula :- InChI Key :SPMVMDHWKHCIDT-UHFFFAOYSA-N
M.W : 454.86 Pubchem ID :9911830
Synonyms :
KRN951;AV-951;KRN-951, Tivozanib
Chemical Name :1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea

Physicochemical Properties

Num. heavy atoms : 32
Num. arom. heavy atoms : 21
Fraction Csp3 : 0.14
Num. rotatable bonds : 8
Num. H-bond acceptors : 7.0
Num. H-bond donors : 2.0
Molar Refractivity : 120.0
TPSA : 107.74 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.21 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.67
Log Po/w (XLOGP3) : 4.03
Log Po/w (WLOGP) : 5.26
Log Po/w (MLOGP) : 2.11
Log Po/w (SILICOS-IT) : 3.5
Consensus Log Po/w : 3.71

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.16
Solubility : 0.00317 mg/ml ; 0.00000697 mol/l
Class : Moderately soluble
Log S (Ali) : -6.0
Solubility : 0.000459 mg/ml ; 0.00000101 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -8.5
Solubility : 0.00000145 mg/ml ; 0.0000000032 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.58
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: